Cyclopropylamine derivatives useful as LSD1 inhibitors
US9676701B2 · kind B2 · utility
6Cited by
27References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2015 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Mar 6, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to cyclopropylamine compounds, in particular the compounds of Formula (I), and their use in therapy, including e.g. in the treatment or prevention of cancer, a neurological disease or condition, or viral infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.